Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. (SHE:301290)
28.09
-0.26 (-0.92%)
At close: Sep 4, 2026
SHE:301290 Revenue
Jiangsu Canopus Wisdom Medical Technology had revenue of 89.83M CNY in the quarter ending June 30, 2026, a decrease of -14.53%. This brings the company's revenue in the last twelve months to 384.50M, down -5.11% year-over-year. In the year 2025, Jiangsu Canopus Wisdom Medical Technology had annual revenue of 387.49M, down -11.02%.
Revenue (ttm)
384.50M
Revenue Growth
-5.11%
P/S Ratio
7.28
Revenue / Employee
528.89K
Employees
727
Market Cap
2.80B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 387.49M | -47.97M | -11.02% |
| Dec 31, 2024 | 435.46M | 1.73M | 0.40% |
| Dec 31, 2023 | 433.73M | -8.36M | -1.89% |
| Jan 1, 2023 | 442.10M | -4.40M | -0.99% |
| Jan 1, 2022 | 446.50M | 72.07M | 19.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.69B |
| Ningbo David Medical Device | 584.68M |
| Chison Medical Technologies | 441.10M |
| Tellgen | 392.11M |
| Nanjing Medlander Medical Technology | 383.30M |
| Zhejiang Tailin BioEngineering Co.,Ltd | 359.10M |
| Kontour (Xi'an) Medical Technology | 351.72M |
| Beijing Leadman Biochemistry | 317.79M |